Gastrin-releasing peptide, neuromedin B, and symptom severity in adult attention-deficit hyperactivity disorder

CONCLUSION: The findings suggest that gastrin-releasing peptide, in particular, may be associated with clinical symptom severity in adult attention-deficit hyperactivity disorder and is a potential biomarker candidate.

via https://pubmed.ncbi.nlm.nih.gov/42879589/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1HYeX0emtvYgH07Wkz0a8n9otrdMd-JIklc_uo0I5vh1u9WMEy&fc=None&ff=20261016010807&v=2.20.1